New Data from MSD Animal Health Demonstrates that Intranasal Vaccination Against Bovine Coronavirus with BOVILLIS® NASALGEN®-C (Lyophilisate and Solvent for Suspension for Cattle) Significantly Improves Production in Veal Calves
Vaccinated calves showed fewer lung lesions and achieved a significantly higher body weight than unvaccinated calves Rahway, N.J., October 23, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of new data in support of intranasal vaccination for the prevention of bovine coronavirus (BCoV) […]
